首页> 外国专利> USE OF DEXTRAN COVALENTLY BOUND TO CHARGED GROUPS FOR SELECTIVE TARGETING OF TUMOR BY LOCAL, INTRATUMORAL OR INTRACAVITARY ADMINISTRATION

USE OF DEXTRAN COVALENTLY BOUND TO CHARGED GROUPS FOR SELECTIVE TARGETING OF TUMOR BY LOCAL, INTRATUMORAL OR INTRACAVITARY ADMINISTRATION

机译:使用共价结合于带电基团的Dextran通过局部,颅内或颅内给药选择性靶向肿瘤

摘要

A compound for local, i.e. intratumoral or intracavitary administration, fortargeting tumors comprising dextran, the charge of whichhas been modified through covalent binding of charged groups, such as chargedamino acids. The compound further comprises a functionalgroup for treating or imaging the tumor.
机译:用于局部,即肿瘤内或腔内给药的化合物靶向包含右旋糖酐的肿瘤,已通过带电基团(例如带电基团)的共价结合进行了修饰氨基酸。该化合物还包含官能团治疗或成像肿瘤的小组。

著录项

  • 公开/公告号CA2347424C

    专利类型

  • 公开/公告日2009-12-08

    原文格式PDF

  • 申请/专利权人 MAP AB;

    申请/专利号CA19992347424

  • 发明设计人 HOLMBERG ANDERS;

    申请日1999-10-12

  • 分类号A61K47/48;A61K51/06;A61P35;

  • 国家 CA

  • 入库时间 2022-08-21 18:42:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号